ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / SNDL
CGC (41) USNA (50) OBIO (34) ACB (54) ⌘ Pro Terminal →

SNDL Inc. (SNDL) — RQD Stock Rating Cockpit

$1.27 +2.42% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.27

SNDL Inc. (SNDL) carries a Roarable Rating of D (Sell) with 47/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $301.7M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on SNDL Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is SNDL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, SNDL Inc. (NASDAQ: SNDL) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $1.27 (+2.42% 1D, market cap $301.7M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 9/20. Across 1015 tracked Health Care issuers, SNDL ranks #309 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does SNDL compare to CGC and USNA in the Health Care sector?
▼

Within the Health Care sector (Medicinal Chemicals and Botanical Products), SNDL carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CGC (Canopy Growth Corporation) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $276.0M) and USNA (USANA Health Sciences Inc.) posts a D grade (50/100 RQD, P/E 24.6x, ROIC 7.9%, cap $264.4M). Among the 5-stock peer group, USNA leads on earnings multiple (24.6x) while USNA leads on capital efficiency (7.9% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for SNDL?
▼

For SNDL Inc. (SNDL), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity and sector rank #309 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.27 (+0.25%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0.2% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510047
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+
Cash (12)Whales (5)SEC (13)Macro (8)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-4.7% Base Target
$2 Bull$1 Base$1 Bear
📬 FREE SNDL RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SNDL)Realized 20D OHLCV Swing Band: ±8.5%
Deterministic 5-Pillar Attribution (47/100 Composite)
🔍 WHY SNDL SCORES 47/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (28% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)

SEC XBRL Trailing 12 Months: 0.2% FCF Margin ($8.4M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning5/20 pts (-15 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
39
Grade E$1.16+10.3% Next Q
Q2 (-2Q)
42
Grade D$1.28+1.6% Next Q
Q3 (-1Q)
44
Grade D$1.30-2.3% Next Q
Current
47
Grade D$1.27-5.9% Hist 90D α
Trajectory: E (39) → D (47)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a SNDL Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While SNDL currently carries a cautious 47/100 (D) rating due to Whale & Options Positioning (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.32) and Max Pain ($1.33) forces dealer call-delta covering toward $2.46.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SNDL• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “SNDL Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
YES 47%NO 53%Trade / Inspect Odds →
RSI-14 MOMENTUMNEUTRAL RANGE
4530 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
7 / 99-Pt Accounting
52-WEEK LASER RANGE12% OF RANGE
L: $1$1.27H: $2
1. Money & Cash Health● MIXED
Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: C-RQD 12 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 14 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D+RQD 21 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on SNDL

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
NEUTRAL (60)

14.0% ROIC with 42.0% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
NEUTRAL (65)

Altman-Z 4.20 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (37)

14/40 institutional & smart-money positioning score with 8/20 macro alignment.

Bull Case: Why Buyers Like SNDL
  • ✓Established market leader in Health Care with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SNDL)

  • ✓Walkthrough of SNDL's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
SNDL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -10.56%▼ DESCENDING CHANNEL
2026-11-03O $1.30H $1.30L $1.24C $1.27VOL 1.39M
RES: $1.44SUP: $1.12SMA50: $1.32SMA200: $1.39
$1.88$1.68$1.47$1.27$1.07RES $1.44SUP $1.12$1.272026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SNDL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SNDL Butterfly Map → + Track SNDL →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on SNDL today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SNDL. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for SNDL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SNDL)

Health Care Rank #309 of 1015 ⚔️ CGC vs SNDL Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SNDL vs. CGC, USNA, OBIO, ACB)

Industry: Medicinal Chemicals and Botanical Products (23 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, SNDL Inc. (SNDL) ranks #309 by composite RQD confidence (47/100, grade D) and #516 by equity capitalization ($301.7M). Within this direct 5-issuer industry benchmark cohort, USNA leads on earnings valuation at 24.6x trailing P/E, while USNA leads on capital efficiency and profitability with 7.9% ROIC and 78.3% gross margin. ACB currently holds the highest overall quantitative score in the immediate peer group at 54/100 (D+) compared with SNDL at 47/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
SNDL ACTIVE
SNDL Inc.
D 47/100 — — — +2.42% $301.7M Benchmark Subject
CGC
Canopy Growth Corporation
D- 41/100 — — — +4.34% $276.0M /cgc-vs-sndl →
USNA
USANA Health Sciences Inc.
D 50/100 24.6x 78.3% 7.9% +2.87% $264.4M /usna-vs-sndl →
OBIO
Orchestra BioMed Holdings Inc.
E 34/100 — 96.0% -35.0% -3.72% $355.2M /obio-vs-sndl →
ACB
Aurora Cannabis Inc.
D+ 54/100 — — — +3.94% $251.5M /acb-vs-sndl →

2. SNDL Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

SNDL Inc. (SNDL) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $301.7M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. SNDL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SNDL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, SNDL Inc. (NASDAQ: SNDL) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $1.27 (+2.42% 1D, market cap $301.7M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 9/20. Across 1015 tracked Health Care issuers, SNDL ranks #309 in composite RQD confidence.

How does SNDL compare to CGC and USNA in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), SNDL carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CGC (Canopy Growth Corporation) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $276.0M) and USNA (USANA Health Sciences Inc.) posts a D grade (50/100 RQD, P/E 24.6x, ROIC 7.9%, cap $264.4M). Among the 5-stock peer group, USNA leads on earnings multiple (24.6x) while USNA leads on capital efficiency (7.9% ROIC).

What are the biggest fundamental strengths and SEC risk factors for SNDL?

For SNDL Inc. (SNDL), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity and sector rank #309 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is SNDL trading relative to its 50-day, 200-day, and 52-week technical levels?

SNDL last traded at $1.27 (+2.42% on volume of 1,233,862 shares), positioning the stock -3.79% below its 50-day simple moving average ($1.32) and -8.63% below its 200-day simple moving average ($1.39). Across its 52-week range of $1.13 to $2.34, SNDL sits at the 11.6% percentile with a 14-day RSI of 45.0 (NEUTRAL RANGE) and an implied next-earnings move of ±8.5% ($1.16 to $1.38).

Direct Sub-Reports: SNDL RQD Cockpit SNDL 12M Forecast SNDL Earnings & Move SNDL Dividends & DRIP SNDL Insiders & 13F SNDL Whale Options SNDL Profit Sankey SNDL News & Why
ROARABLE RATING BRIEF • RQD 47/100 (D) ✓ SEC XBRL & RQD VERIFIED

SNDL — SNDL Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-11-03

1. Roarable Rating Brief: What This Means to a Prospective Investor

SNDL Inc. (SNDL) earns a live Roarable RQD composite score of 47/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $1.27 (+2.42% 1D, market capitalization $301.7M).

  • Fundamental Cash Engine (12/20): Anchored by return on invested capital (ROIC) of —, gross margin of —, operating margin of —, and free cash flow yield of —.
  • Whale 13F & Options Flow (5/20) + Insider Conviction (9/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of N/A, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Sector: Health Care. Industry: Medicinal Chemicals and Botanical Products. Exchange: NASDAQ.. Is a NASDAQ-listed issuer in this industry with a market capitalization of $0.3B. — describes its specific products, customers, or revenue model.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D • RQD 47/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 5/20. With Fundamental Cash Engine at 12/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $1.13 – $2.34 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Medicinal Chemicals and Botanical Products (Health Care), SNDL carries a macro regime beta of 1.00 and gross margin of —.

  • Key Question #1: Can SNDL sustain or expand its — operating margin and — ROIC against Medicinal Chemicals and Botanical Products peers over the next 4 quarters?
  • Key Question #2: Will free cash flow conversion (— FCF yield) strengthen balance-sheet liquidity (Altman Z-Score N/A) toward the $2.34 52-week high?
  • Key Question #3: How sensitive is SNDL's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

SNDL Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for SNDL Inc. (SNDL) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to SNDL Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

SNDL Bull vs. Bear Conversation Board — What's Your Call at $1.27?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SNDL 🐻 33% BEARISH CONVICTION
1. Pick Your Side on SNDL:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
AL AlphaFlow_Cap RQD DEBATE OPENER • Verified $100K Arena Trader 🐂 BULLISH 🎯 Target: $1.53 (+23.4%)
📌 Pinned Debate

Record Q3 free cash flow and expanded capital returns after shareholders rejected consolidation, per the news wire.

The street is overcomplicating SNDL Inc. (SNDL). Record Q3 free cash flow and expanded capital returns after shareholders rejected consolidation, per the news wire.. With an RQD score of 47/100 (D) and Forensic Balance Sheet at 13/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $1.34.

CapAlloc_Nerd 🐂 BULL

@RiskArb_Desk Fair point on current EV/EBITDA multiples, but you're ignoring the forward operating leverage in Medicinal Chemicals and Botanical Products. If gross margin (0.0%) holds, EPS grows into the multiple faster than bears think.

RI RiskArb_Desk RQD DEBATE OPENER • Hedged Event Driven 🐻 BEARISH 🎯 Target: $0.95 (-23.4%)
Spot @ $1.24

The RQD rating shows 0% ROIC and 0% FCF yield, with a D grade and a distribution-warning verdict.

I respect the product at SNDL Inc., but the stock at $1.24 is a different story. The RQD rating shows 0% ROIC and 0% FCF yield, with a D grade and a distribution-warning verdict.. FCF yield is 0.0% and RQD sits at 47/100 (D) — why pay up here when you can wait for next quarter's numbers?

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%